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Post-translational polypeptide tagging by conjugation with ubiquitin and ubiquitin-like (Ub/Ubl)
molecules is a potent way to alter protein functions and/or sort speciﬁc protein targets to the
proteasome for degradation. Many poxviruses interfere with the host Ub/Ubl system by
encoding viral proteins that can usurp this pathway. Some of these include viral proteins of the
membrane-associated RING-CH (MARCH) domain, p28/Really Interesting New Gene (RING) ﬁnger,
ankyrin-repeat/F-box and Broad-complex, Tramtrack and Bric-a-Brac (BTB)/Kelch subgroups of
the E3 Ub ligase superfamily. Here we describe and discuss the various strategies used by poxviruses
to target and subvert the host cell Ub/Ubl systems.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Members of the Poxviridae family of viruses, which infect di-
verse members of the animal kingdom, are double-stranded DNA
viruses, each encode around 200 proteins. Although biologically
very diverse, poxviruses were originally discovered to be associ-
ated with diseases that produced characteristic pox in the skin
[1]. Taxonomically, the Poxviridae family can be classiﬁed into
two subfamilies: the poxviruses of vertebrates (Chordopoxvirinae)
and the poxviruses of insects (Entomopoxvirinae). Chordopoxvirinae
subfamily currently contains eight genera: Orthopoxvirus, Para-
poxvirus, Avipoxvirus, Capripoxvirus, Leporipoxvirus, Suipoxvirus,
Molluscipoxvirus and Yatapoxvirus. Entomopoxvirinae subfamily
comprises three genera: Entomopoxvirus A, Entomopoxvirus B
and Entomopoxvirus C [2].
Unlike other DNA viruses, the replication of poxviruses occurs
exclusively in the cytoplasm of the infected host cell. Due to the
existence of many diverse host innate antiviral defenses, poxvirus-chemical Societies. Published by E
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ARCH, membrane-associatedes have evolved complex molecular counteracting strategies to
promote infection and disable or re-conﬁgure the host antiviral re-
sponses [3]. Among the myriad of cellular pathways that can be
manipulated by poxviruses, the ubiquitin/ubiquitin-like (Ub/Ubl)
system has drawn considerable attention because many new spe-
ciﬁc poxvirus proteins implicated in modulating the host Ub/Ubl
system have been recently identiﬁed.
Ub is a 76-amino acid containing protein that is covalently at-
tached to target proteins and it is the ﬁrst member of a larger
Ubl protein family [4]. One complexity of the Ub/Ubl-conjugation
pathway is the existence of many Ubl molecules, such as small
ubiquitin-like modiﬁers (SUMO), interferon stimulated gene 15
(ISG15), neural-precursor-cell-expressed developmentally down-
regulated 8 (NEDD8) and the list of new Ubl family members con-
tinues to expand [5]. The conjugation of Ub/Ubl to target protein
substrates regulates diverse biological processes, including: pro-
tein turnover, protein targeting, receptor internalization and regu-
lation of cell signaling. A generic Ub/Ubl-conjugation pathway
involves deubiquitinating enzymes (DUBs) or Ub/Ubl-speciﬁc pro-
teases (USPs), Ub/Ubl-activating enzyme (E1), Ub/Ubl-conjugating
enzyme (E2), and Ub/Ubl-protein ligase (E3) enzymes [6]. The
extraordinary diversity of E2, E3 and DUB/USP enzymes reﬂects
the fact that Ub/Ubl-conjugation and de-conjugation is a highly
conserved cellular regulatory process that needs to be tightly
controlled.
The E3 Ub/Ubl-protein ligases can be divided into ﬁve major
groups. The ﬁrst group consists of HECT domain-containinglsevier B.V. All rights reserved.
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apoptosises (IAPs), and other Really Interesting New Gene (RING)
ﬁnger-containing proteins, which usually contain both the E2-
binding domain and the substrate recognition motif in a single
polypeptide chain [8]. In contrast, the third group of E3 ligases con-
sists of large protein complexes that contain a minimal ligase core
consisting of a cullin and RING-H2 heterodimer, such as the SCF,
APC and the VBC complexes [9,10]. The fourth group is comprised
of U-box-containing proteins [11]. The ﬁfth group is called mem-
brane-associated RING-CH (MARCH) [12], which contains a RING-
CH domain at the amino terminus followed by two transmembrane
domains.
The larger subject of how other viruses and pathogens interact
with the host Ub/Ubl system has been reviewed previously [5,13–
16]. In this mini-review, we consider the components of the Ub/Ubl
system for which poxviruses have evolved functional modulators.
Speciﬁcally, we focus on the virus-encoded E3 ubiquitin ligases
and examine how poxviruses target and exploit the Ub/Ubl path-
way to evade or subvert the host responses. Finally, we discuss
how various classes of poxviral proteins interfere with the host
Ub/Ubl degradation pathway.
2. Poxvirus-encoded E3 ubiquitin ligases
To be able to successfully colonize a susceptible host, all viruses
have evolved sophisticated strategies to evade the host anti-viral
responses, or to eliminate the blockade generated by innate host
cell defenses that attempt to override virus replication [3,17,18].
For years, one intriguing conundrum relates to how viruses can
cope with the various host innate and acquired immune responses
and survive to successfully replicate and disseminate. The recent
discovery of a novel family of virus-encoded proteins with Ub/
Ubl ligase activity (called viral E3 Ub ligase enzymes) has started
to shed light into the strategies used by viruses to evade or subvert
the host anti-viral responses [12,13]. To date, viral E3 Ub ligase
gene family members have been identiﬁed in the genomes of sev-
eral different large DNA viruses, like the gamma-herpesviruses and
poxviruses [19–24]. The poxvirus-encoded E3 Ub ligases described
to date are presented in Table 1.Table 1
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p28/RING EVM012 (ectromelia) ? [41]
M143 (myxoma) ? [43]






M148, M149, M150 (myxoma) ? [71]
B18R (vaccinia) ? [70]
ORFV008, ORFV123, ORFV126,









EVM150, EVM167 (ectromelia) ? [77]
D11L, C18L, G3L, A57R (cowpox) ? [32]
M006, M008, M009, M014, M140
(myxoma)
?2.1. MARCH poxviral E3 ubiquitin ligases
The function of virus-encoded E3 Ub ligases was originally
linked with the downregulation of cell surface major histocompat-
ibility complex class-1 (MHC-1) molecules, with the concomitant
inhibition of antigen presentation at the virus-infected cell surface
[23,25]. For example, the open reading frames (ORFs) K3 and K5
from Kaposi’s sarcoma associated virus (KSHV-K3 and KSHV-K5,
respectively), and the ORF K3 from murine gamma-herpesvirus
68 (MHV68-K3), two members of the gamma-herpesvirus family,
have been reported to downregulate the expression of MHC-1 mol-
ecules by inducing the rapid internalization and accelerated degra-
dation of MHC-1 molecules in either the lysosomal (e.g. KSHV-K3
or KSHV-K5), or in the proteasome (MHV68-K3) compartments
[19,21,22,24,26]. Likewise, myxoma virus infection also downregu-
lates host MHC-1, as well as certain other cell surface immuno-
modulatory molecules like CD4 and CD95/Fas [23,25].
One characteristic that deﬁnes these viral E3 Ub ligases is the
presence of a RING-CH ﬁnger domain. While the RING-ﬁnger
domain is usually at the carboxy-terminus of the E3 Ub ligase pro-
tein, the RING-CH domain is found at the amino terminus and is
generally followed by two putative transmembrane domains
[27–29]. Different names have been used to refer to the family of
viral membrane-associated proteins with potential E3 Ub ligase
activity, example MIRs [12], scrapins [25,30], or K3 family of im-
mune evasion proteins [23]. Now the term MARCH protein is
widely accepted to describe this family. A schematic model for
the MARCH poxviral E3 Ub ligase is shown in Fig. 1A.
Myxoma virus (MV), a member of the Poxviridae family that
causes the lethal disease called myxomatosis in European rabbits
(Oryctolagus cuniculus), has a canonical double-stranded DNA
genome whose replication occurs exclusively at the cytoplasm
[31]. Among the 160 proteins encoded by the MV genome, those
that are expressed by genes localized within or close to the ter-
minal inverted repeats are frequently implicated in the regula-
tion of the host response to infection [32]. In 2002, the M153R,
a RING-CH containing protein was shown to be a virulence factor
for myxomatosis in rabbits [25] (Table 1). This MV protein was
implicated in the downregulation of the host cell surface MHC-
1, the pro-apoptotic factor CD95 (Fas) and the activated leuko-
cyte cell adhesion molecule (ALCAM) [33]. M153R is expressed
as an early protein that localizes to the endoplamic reticulum
(ER) and trans Golgi network in transiently transfected cells
[23,25] which translocates to the trans Golgi network during
virus infection [23]. The previously observed endocytosis and
lysosomal degradation of the host MHC-1 in MV-infected cells
[34] is now thought to be mediated by the M153R protein. In
1995, it was reported that cell surface protein receptor CD4
was downregulated and degraded following infection of rabbit
CD4+ T-cells with MV [35]. Later, Mansouri et al. [23] demon-
strated that M153R was responsible for the inhibition of CD4
in a fashion similar to that for MHC-1.
The question that then arises is how M153R removes the CD4
receptor from the MV-infected T-cell surface. Although the an-
swer for this question is still incomplete, it is clear that internal-
ization by endocytosis followed by degradation of CD4 in the
lysosomes is mediated or accelerated by M153R. Some light
has been shed about the requirements for the CD4 degradation
[23]. First, the cytosolic tail of CD4 has to possess at least one
residue of lysine, which is recognized and ubiquitinated when
M153R is present. Second, the RING-CH domain in the M153R
protein is necessary to ubiquitinate CD4, suggesting that the
RING-CH domain acts as a bona ﬁde viral E3 Ub ligase. These
requirements are also extended to other M153R substrates, like
the cell surface MHC-1 molecules, whose degradation is also
mediated by the M153R protein.
Fig. 1. A schematic of different classes of poxvirus E3 ubiquitin ligases: (A) Membrane-associated RING-CH (MARCH) E3 ubiquitin ligase. Transmembrane regions of MARCH
and its targets mediate an interaction, then the N-terminal RING-CH domain of the MARCH recruits E2, and transfer the ubiquitin to the cytosolic tail of the target. (B) p28
RING E3 ligase. C-terminal Really Interesting New Gene (RING) domain of p28 ubiquitin ligase recruits E2 and facilitates the ubiquitination of target. (C) Skp1-Cul1-F-box
(SCF) E3 ligase. Scaffold module Cul1 interacts with skp1 and the catalytic module RING domain protein Roc1. Skp1 binds to the C-terminal F-box domain of viral substrate
recognition module, which links the substrate through N-terminal Ankyrin (ANK) repeats. (D) BTB-BACK-Kelch (BBK)/Cul3 E3 ubiquitin ligase. Cul3 is a scaffold module that
interacts with the RING domain of protein Roc1 (the catalytic module) and with the N-terminal BTB domain of the viral substrate recognition module. This binding occurs
through C-terminal Kelch domain.
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Ectromelia virus (EV) is an orthopoxvirus and the causative
agent of mousepox [36]. One of the EV proteins implicated in alter-
ing the host response during viral infection is p28. This viral pro-
tein contains a RING zinc ﬁnger at the carboxyl terminal domain
(p28-RING containing protein), and is considered a signiﬁcant vir-
ulence and anti-apoptotic factor in mice infected with EV [37–40]
(Table 1).
Orthologs of the p28-RING containing protein have also been
identiﬁed in other orthopoxviruses, like variola major virus
(VARV), cowpox (CPXV), monkeypox (MPXV), and the strain IHD-
W of vaccinia virus (VV) [41]. A related family member has also
been found in the genomes of Shope ﬁbroma virus (SFV) and MV,
two members of the Leporipoxvirus genus [42]. Ten ORFs with
homology to the p28-RING protein also exist within the Fowlpox
virus genome [23,43]. The conservation of this protein throughout
different poxvirus genera, but not all, supports its role in virus
pathogenesis and/or host range [44].
Different observations have correlated the pathogenesis of pox-
viruses that express p28 members with the presence of the RING
zinc ﬁnger motif. In fact, this motif has been linked to the promo-
tion of virus virulence in vivo and the inhibition of cellular apopto-
sis during virus replication in vitro. It is known that apoptosis is an
innate cellular defense mechanism to block virus replication [39].
Although p28 is not essential for poxvirus replication in cell cul-
ture, this protein is necessary for EV pathogenesis in mice [40],
where the host morbidity was reduced and even eliminated upon
infection with the mutant p28 (p28) compared to the infection
with EV wild-type [40]. In addition to this, mutation of p28 demon-strated that the expression of this protein is required for optimal
EV replication in murine peritoneal macrophages [40,41,43,45].
These observations suggest that the role of p28 may also be related
to virus host range, in addition to evasion of the innate anti-viral
response.
Other studies have revealed that during infection of T cells and
macrophages with EV, p28 is polyubiquitinated and localized in
cytoplasmic viral factories [43]. Furthermore, these studies also
demonstrated that, although ubiquitination of p28 appears to be
RING-dependent, the localization of p28 in viral factories is
RING-independent. This last observation suggests that p28 is
ubquitinated itself in these compartments [43,45].
In vitro studies showed that RING-ﬁnger proteins of different
members of the Orthopoxvirus genus, like p28 from EV (EVP28),
its homolog from variola virus (SP28), and M143R from MV, are
all viral E3 Ub ligases [45]. Moreover, the RING domain of both
EVP28 and SP28 proteins was found to be necessary to maintain
the E3 Ub ligase activity [43,45]. As a viral E3 Ub ligase, p28 ap-
pears to catalyze the ubiquitination of multiple protein substrates,
as illustrated in Fig. 1B. The p28 dependent ubiquitination of its
substrate(s) occurs in concert with E2 Ub conjugating enzymes like
Ubc4, UbcH5c, and UBc13/Uev1A [46].
Although signiﬁcant advances have been made in elucidating
the connection between the role of the E3 Ub ligase p28 with viral
replication in vitro, and the evasion of the host anti-viral re-
sponses in vivo, there are other aspects that remain to be better
deﬁned. For example, the nature and number of its key target
substrates (i.e. host and/or viral), the mechanisms that govern
its catalytic activity, and basis of the anti-apoptotic responses
are all unknown.
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Originally discovered in insect viruses [47], proteins with Bacul-
oviral IAP repeat (BIR) motifs have been thought to function pri-
marily as inhibitors of apoptosis (IAP). Subsets of IAPs contain a
RING domain and maintain Ub ligase (E3) activity [48]. In this case,
the BIR domain brings targeted molecules into proximity with Ub
protein ligase for ubiquitination.
Viral IAPs exist in two insect poxviruses: Amsacta moorei ento-
mopoxvirus (AmEPV) and Melanoplus sanguinipes entomopoxvi-
rus (MsEPV). AMV021 from AmEPV (AMV-IAP) contains two BIR
motifs and a C-terminal RING-ﬁnger domain whereas MSEV248
from MsEPV contains one BIR domain and RING-ﬁnger domains
[48]. It was conﬁrmed that AMV-IAP functions as a bona ﬁde
anti-apoptotic protein [49]. In vitro studies have revealed that
AMV-IAP inhibits the activities of caspases 3 and 9 [47]. Other
studies performed in Drosophila have shown that IAP-binding mo-
tif proteins (IBMs) protect the cells from apoptosis induced by the
proteins Hid and Grim [49]. In this case, in vitro and in vivo studies
have revealed that the AMV-IAP domains BIR1 and BIR2 interact
with Grim and Hid, respectively [50].
Future studies will likely focus on whether the RING domain of
IAP members is involved in the ubiquitination of pro-apoptotic
substrates.
2.4. APC family E3 ubiquitin ligases of poxviruses
Orderly progression through cell cycle relies on the sequential
degradation of cell cycle regulatory proteins mediated by the mito-
tic ubiquitination system. In this system, one key E3 Ub ligase is
the anaphase-promoting complex (APC) or cyclosome, which cata-
lyzes the attachment of Ub to the lysine side chains of securin and
mitotic cyclins [51]. The minimal ligase module of APC is com-
prised of APC2 (a distant member of the cullin family) and
APC11 (a RING-H2 ﬁnger protein) [52].
Genome analysis has revealed the presence of homologs of cat-
alytic core subunit of cellular APC/C subunit 11 (Apc11) in poxvi-
ruses, such as Crocodile poxvirus protein CRV047 [53],
molluscum contagiosum virus (MOCV) MC026L [54], parapox virus
014 [55] and squirrelpox virus 026L [56]. All of these poxvirus pro-
teins contain a modiﬁed RING-ﬁnger motif similar to the RING-H2
motif of Apc11. A functional role for these viral proteins in the for-
mation and regulation of the E3 Ub ligase complex, however, re-
mains to be investigated.
2.5. Ankyrin-repeat/F-box poxviral proteins
Ankyrin (ANK) repeats and F-box domains were discovered sep-
arately in poxvirus genomes. The ANK repeat is a 33-residue motif
named after the cytoskeletal protein, ankyrin, which contains 24
copies of the repeat and was ﬁrst demonstrated to have a role in
signaling with yeast Cdc10 [57,58]. ANK repeats mediate a diverse
range of protein-protein interactions and have been found in a
wide variety of archaeal, bacterial and eukaryotic proteins [59].
The presence of Pox protein Repeats of ANkyrin-C terminal
(PRANC) domain was reported soon after the motif was named
[60]. Shchelkunov et al. analyzed the coding sequences of variola
major virus strain India-1967 genome and vaccinia virus strain
Copenhagen genome and found a group of viral proteins which
contain ANK repeats [61]. Because two vaccinia host range pro-
teins, M1 and K1, are PRANC-containing proteins it was proposed
that the expression levels of different sets of the PRANC proteins
allow the ﬁne regulation and determination of tissue tropism.
The F-box motif is a sequence domain of about 50 amino acids
named after cyclin F, which contains one F-box [62]. F-box protein
was originally discovered in one of three components of the SCF(Skp1, Cul1 and F-box) complex, which facilities the ubiquitination
of proteins targeted for degradation by the proteasome. The F-box
motif interacts with the Skp1 adaptor protein directly, and cellular
F-box proteins commonly carry other protein-protein interaction
motifs such as leucine-rich repeats and WD repeats [63].
In PRANC/F-box proteins, the F-box is at the C-terminus, which
is not in the case for cellular F-box proteins. Also, cellular F-box
proteins are generally not associated with ankyrin-repeat domains
although they are sometimes associated with SOCS box domains.
Given that F-box domains in host proteins are linked to E3 Ub li-
gase activity, it is fair to hypothesize that poxvirus PRANC/F-box
proteins may interact with cellular SCF complexes (Fig. 1C). The
ﬁrst experimental evidence that supports this hypothesis came
from work with M-T5, one of four MV PRANC/F-box proteins. M-
T5 was originally identiﬁed as a virus virulence factor, based on
the observation that the deletion of both copies of the viral M-T5
gene attenuated myxomatosis dramatically in susceptible rabbits
infected with the M-T5 knockout virus [64]. Moreover M-T5 was
shown to be a critical determinant of cell tropism in vitro for both
rabbit T-lymphocytes and a subset of human cancer cells [65]. M-
T5 encodes a protein with seven ANK repeat domains at the N-ter-
minus, and a C-terminal F-box motif. M-T5 can be co-immunopre-
cipitated with host cell cullin-1 (cul-1) and co-localizes with cul-1
in the nucleus [65]. Increased transition out of G0/G1 arrest in-
duced by serum deprivation was observed following MV infection
of permissive cells. However, this effect was not observed follow-
ing infection by M-T5 knockout MV. These results suggest that
M-T5 functions as a virus-encoded cell cycle regulator capable of
overcoming induced growth arrest at the G0/G1 checkpoint. Regu-
lation of the cell cycle at the G0/G1 checkpoint by host cul-1 in-
volves control of the expression and activity of p27/Kip1 [66]. In
this process, transition through G0/G1 requires ubiquitination of
p27 by cul-1/SCF and subsequent degradation through the 26S pro-
teasome pathway [67]. Thus, M-T5 promotes the phosphorylation,
ubiquitination, and degradation of p27 in MV-infected cells. Fol-
lowing the expression of M-T5, p27 is phosphorylated at Thr187
and then the degradation of p27 is subsequently observed. Addi-
tionally, Akt is another cellular binding partner for M-T5 [68].
However, whether p27 (or any other SCF complex member) be-
comes a substrate of activated Akt remains to be determined.
M150 is another ANK repeat/PRANC viral protein with nine N-
terminal ANK repeats and a C-terminal F-box and which is essen-
tial for MV pathogenesis in rabbits. When transiently expressed
in transfected cells, M150 protein was found to localize in the nu-
cleus with a punctate pattern which was eliminated when the
eighth ANK repeat was deleted [69]. In TNFa-stimulated cells,
NFjB p65 co-localized with M150 in the nucleus, which suggests
that M150 interferes with the NFjB pathway. In this regard, the
cellular inhibitor of NFjB, called IjB, also contains ANK repeats,
but how M150 modulates NFjB signaling remains to be elucidated
The M148 protein of MV contains 10 ANK repeats and is local-
ized in both the cytoplasm and the nucleus [69]. Nine ANK repeats
have been identiﬁed in M149 protein and a punctuate pattern with
a uniform distribution in the cytoplasm was observed for this MV
protein. Neither M148 nor M149 proteins are required for virus
replication in tissue culture, but they are both virulence factors
in MV-infected rabbits [70]. The binding partners and potential tar-
get substrates for M148, M149 and M150 need to be reported.
In orf virus, a member of parapox virus genus that causes local-
ized skin infections in goats, sheep and humans, ﬁve PRANC/F-box
proteins have been identiﬁed to interact with host cell Skp1 in an
F-box dependent manner [70]. Compared with most cellular F-box
motifs, poxviral F-box domains tend to be shorter, sometimes
spanning only the ﬁrst two of three a-helices in cellular F-box pro-
teins. All ﬁve orf virus proteins interact with endogenous Skp1,
cul1 and Roc1. Moreover, ORFV008 association with SCF does not
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lular SCF complex [71]. Taken together, it is likely that poxviruses
utilize these ANK/F-box proteins to recruit novel target proteins to
SCF1 Ub ligases and exploit the host Ub-proteasome machinery to
degrade speciﬁc cellular (and possibly viral) proteins to favor virus
replication in some fashion.
Vaccinia B18R is highly conserved among orthopoxviruses and
also contains ANK repeats and an F-box. From yeast-two-hybrid
screenings, Sperling et al. reported that Skp1a is a binding partner
for B18R [72]. They conﬁrmed this interaction by co-IP and such
interaction was shown to be F-box dependent.
In EV, the causative agent of lethal mousepox, the ANK-repeat/
F-box proteins EVM002, EVM005 and EVM154 were shown to be a
part of the cellular SCF complex [72]. Barry et al. also showed that
EVM005 protein co-localizes with cellular cul-1 [72]. EVM005 was
co-precipitated with cul-1, Skp1 and Roc1. In addition to this,
EVM005 was associated with conjugated Ub. The interaction be-
tween EVM005 and Skp1/cul-1 is F-box dependent. Finally,
EVM002 and EVM154 interact with Skp1 and conjugated Ub [72].
All of these results are consistent with the systematic modulation
of the host cell SCF complexes to target novel substrates for ubqui-
tination and degradation.
Cowpox protein CP77 is a PRANC/F-box protein that contains
nine ANK repeats and a relatively short C-terminal 13aa F-box mo-
tif. Chang et al. have recently found that CP77 inhibits the NFjB
activation induced by TNFa or IL-1 (Chang, personal communica-
tion). Interestingly, the 13aa F-box in CP77 is shorter than most
other poxvirus F-box motifs, which suggests it could deﬁne a min-
imum motif requirement for binding to the cellular SCF complex.
Although CP77 protein acts as a host range protein for vaccinia
virus in some cell lines, this short F-box motif, which is important
for binding SCF complex, is not required for the host range function
of CP77.
As discussed, poxviruses encode a family of PRANC/F-box pro-
teins which can bind Skp1 through the viral F-box domain
(Fig. 1C). Cullin-based Ub E3 ligases contain three functional com-
ponents: a catalytic module composed of a small RING domain pro-
tein that recruits the Ub-conjugating enzyme E2, cullin as a
scaffold module, and a substrate recognition module that binds
to the substrate and brings it within proximity to the catalytic
module [73].
2.6. BTB/Kelch (BBK) poxviral proteins
Recently, the molecular composition and function of the cullin-
3-dependent E3 ligase complex has been described [74]. In this
complex, Broad-complex, Tramtrack and Bric-a-Brac (BTB) do-
main-containing proteins mediate binding of the cullin to the sub-
strate. Poxviruses are the only family of viruses known to encode
BTB-BACK-Kelch (BBK) proteins [75], suggesting that poxvirus
might also modulate the host Ub pathway through interaction with
cullin 3 (Fig. 1D).
The BTB domain of EV BBK protein EVM150 and EVM167 are
necessary and sufﬁcient for interacting with N-terminal region of
cullin 3 [75]. Moreover, EVM150 and EVM167 interact with conju-
gated Ub and Roc1, the RING-ﬁnger protein that functions as the
Ub ligase. Taken together, EVM150 and EVM167 support the for-
mation of active cullin-3-based Ub ligases recruiting still-unidenti-
ﬁed substrates for ubiquitination (Table 1). Another two BBK
proteins, EVM18 and EVM27, also interact with cullin 3 (Wilton
and Barry, personal communication). Whether all BTB/Kelch pro-
teins in poxvirus are involved in the Ub/Ubl pathway, or target
other host pathways, needs to be investigated.
Functional evidence indicates important roles for BBK proteins
during the poxvirus life cycle. Deletion of BBK genes in cowpox re-
duces the number of mature progeny [77]. In mice, intranasalinfection of viral BBK gene deletion mutants showed reduction of
the virulence, indicating an important role for BBK proteins in viral
pathogenesis. Deletion of Cowpox BTB/Kelch genes (D11L, C18L,
G3L and A57R) also reduces the cytopathic effect as well as the for-
mation of cellular protrusions in vitro (Shchelkunov, personal com-
munication). In the Sheeppox virus (SPPV) BBK protein SPPV-019
has been reported to be a signiﬁcant virulence factor [78]. When
infected with the SPPV-019 knockout virus, cells exhibited a reduc-
tion in calcium-independent cell adhesion, suggesting that SPPV-
019 may modulate cellular adhesion. When inoculated into sheep
by the intranasal or intradermal routes, the SPPV-019 knockout
virus became attenuated [78].
Vaccinia virus encodes three BBK family proteins: C2L, F3L and
A55R [79–81]. Knockout virus constructs for individual BBK pro-
teins were attenuated in the murine intradermal model, but their
roles in any host cell Ub/Ubl pathway is still elusive.3. Ubiquitin-like (Ubl) pathways
Since Ub conjugation was discovered in mid-1970s [4,82], a
number of small proteins related to Ub have been identiﬁed [6].
The Ub-like proteins (Ubl) share a similar 3D structure, featured
by the Ub or beta-grasp fold, despite the low similarity in amino
acid sequences [83].
3.1. SUMOylation
As a post-translation modiﬁcation, the Small Ubiquitin-like
Modiﬁers (SUMO-1, SUMO-2 and SUMO-3) are covalently attached
to target protein substrates to inﬂuence their sub-cellular parti-
tioning and protein stability [84,85].
A vaccinia protein called A40 was found to be associated with
the cytosolic site of the ER, but SUMO-1 conjugation induced the
relocation of A40 into the DNA-replication site and lysine 95 was
the key SUMOylation residue for A40 [86]. The role of the SUMO-
1 modiﬁed form of A40 could be in late viral transcription that is
known to occur at vaccinia virus replication sites or it could be
an integral component in the process of replication itself [87].
Vaccinia protein E3 is a double-stranded RNA binding protein
that has been shown to interact with SUMO-1 by yeast two hybrid
assays [88]. However, E3 is not thought to become SUMO-1 conju-
gated itself because during virus infection the observed molecular
mass of the E3 protein is not overtly changed, as measured by gel
electrophoresis. It is likely that SUMO-1 modiﬁes other proteins in
a way that favors viral replication, but the role of E3 protein re-
mains to be better deﬁned.3.2. ISGylation
ISG15 encodes a 17 kDa small Ubl protein that is transcription-
ally regulated by interferon (IFN) a and IFN b and forms covalent
conjugates (ISGylation) with targeted proteins [89]. By utilizing
activating, conjugating and ligating enzymes, ISG15 facilitates the
addition of ISG15 to speciﬁc lysine residues of substrate proteins
and may alter the subcellular localization, structural stability, or
the activities of them [6]. For instance, ISG15 targets many innate
antiviral proteins, including: PKR, STAT1 [90], JAK1 and RIG-I [91],
and may regulate their activity during viral infection.
ISG15 mRNA of Hela cell was upregulated after infection with
MVA and NYVAC but not with the WR strain of vaccinia virus
[92,93]. Moreover, mRNA of ISG15 was increased when infected
with VVDE3 compared with WR [94]. ISG15 interacts with the
C-terminal domain of E3, by which E3 suppresses the antiviral
function of ISG15 [95]. VVDE3L caused signiﬁcant disease and
mortality in ISG15-deﬁcient mice, which is not observed in
612 L. Zhang et al. / FEBS Letters 583 (2009) 607–614ISG15+/+ mice. Compared with ISG15+/+-infected mice, ISG15-
deﬁcient mice infected with VVDE3L or with an E3L mutant virus
lacking the C-terminal domain triggered an enhanced inﬂamma-
tory response in the lungs [95].
4. Miscellaneous poxvirus strategies to modify Ub/Ubl pathways
4.1. Deconjugating enzymes
Removal of Ub or Ubls from substrates by deconjugating en-
zymes is another step that pathogens can hijack [96]. Several
members from the families of cellular metalloproteases and cys-
teine proteases have been deﬁned to be responsible for the Ub
deconjugation in the cell, for instance, Ub-speciﬁc proteases (USPs,
also referred to as Ub processing proteases, UBPs), Ub C-terminal
hydrolases (UCHs), ovarian tumor related proteases/Cezanne
(OTUs), and Josephin domain proteases (JD) [5].
The I7L protein of vaccinia virus and the adenovirus protease
Avp (a deubiquitin and deISGlatin enzymes) share the critical res-
idues that surround the catalytic triad of proteinases found in the
Ub pathway for protein degradation, such as the YopJ proteinase
in Yersinia pestis [97]. I7L belongs to the peptidase_C57 superfam-
ily. The substrate speciﬁcity for I7L has been deﬁned as AG/X,
where X in the P10 position has a preference for a small residue
like Ala, Ser or Thr [98]. I7L is required for AG/X-speciﬁc cleavages
of viral membrane and core proteins, which occur at early and late
stages of virus assembly, respectively [98]. It remains to be inves-
tigated whether I7l is a true Ub/Ubl deconjugating enzyme.
4.2. Poxviruses encoded homologs of ubiquitin
Ubiquitin has been detected in vaccinia virions and suggests
that ubiquination of viral or host proteins is an important process
[99,100]. Proteins with sequence similarity to ubiquitin are present
in the genomes of entomopox and canarypox virus. For example,
the entomopox virus MSV144 is an example of one such ubiquitin
homolog. The amino acid identity between MSV144 and eukaryotic
ubiquitin is from 83% to 88% [101]. Likewise, CNPV096 from
canarypox virus is a homolog of cellular ubiquitin as well [102].
Although it has been suggested that poxvirus virulence and host
range are inﬂuenced by Ub homologs, the precise roles of these
proteins needs to be investigated.4.3. Poxviral proteins that interfere with host protein Ub-degradation
Besides components of E3 Ub ligase complex and deconjugation
enzymes, poxviruses also encode different proteins that inhibit or
enhance the host Ub/Ubl system for their own advantage.
TRAF6 an E3 Ub ligase that functions to activate TLR signaling
can be inhibited by several proteins encoded by poxviruses [103].
The TRAF domain of TRAF6 is necessary and required for the inter-
action with vaccinia A52 protein [104]. By direct binding, A52 dis-
rupts the TRAF6-TAB1-containing complex, activates p38 MAP
kinase and inhibits TLR3 induced NFjB activation [104,105]. In a
murine intranasal model, the vaccinia A52 deletion mutant virus
caused milder signs of illness and reduced weight loss compared
to the effects of wild-type virus, thus suggesting that the A52 pro-
tein contributes to virus virulence [104]. Another vaccinia protein,
K7, not only shares the intracellular targets of A52, such as TRAF6
and IRAK2, but also interacts with DDX3 and plays a role in the
TBK1/IKKe-mediated IRF activation [106].
The protein level of p53 plays an important role in apoptosis
and cell cycle control. The cellular p53 protein levels are tightly
controlled by binding to an E3 Ub ligase, Mdm2, which promotes
its ubiquitination and subsequent proteolytic degradation [107].The interaction between p53 and Mdm2 is upregulated by phos-
phorylation of p53 at its N-terminus. The vaccinia B1R kinase is
an early protein required for viral DNA replication that phosphor-
ylates p53 and facilitates the recruitment of p53 to Mdm2 for ubiq-
uitination [108].
5. What is the role of the host cell proteasome?
While it is apparent that poxviruses encode a wide variety of
proteins that regulate the Ub-proteasome system, the role of the
26S proteasome during poxvirus infection has only recently been
investigated. For example, orthopoxvirus infection is dramatically
affected by a range of proteasome inhibitors, such as MG132,
MG115, lactacystin and Velcade (Barry, personal communication).
Treatment of vaccinia virus-infected cells with MG132 or Velcade
results in a failure of viral replication factories to appear within
the cytoplasm. This is accompanied by the absence of late viral
gene expression and DNA replication, whereas, early viral gene
expression is unaffected. Proteasomal inhibition with MG132 or
Velcade also has dramatic effects on viral progeny titer, severely
blocking viral replication. One possible explanation for the effect
of MG132 on poxviral infection is due to lack of available ubiquitin
because MG132 depleted the cellular pool of ubiquitin, but the
mechanism remains to be better deﬁned. The addition of a Ub-acti-
vating enzyme (E1) inhibitor had a similar effect on early and late
protein expression. This suggests that a functional cellular Ub-pro-
teasome system is required during poxvirus infection. However,
the precise target(s) needed for productive viral replication are still
unknown.6. Future prospects
In different ways that share the feature of favoring virus repli-
cation, poxviruses encode not only many diverse proteins as the
potential components of E3 Ub ligase complexes, but also an
impressive set of effectors and inhibitors of various Ub/Ubl
modiﬁcation pathways. Although progress has been made in
understanding the role of poxviral proteins in re-programing host
Ub/Ubl systems, there are many important questions still unan-
swered. Our understanding of the poxvirus E3 Ub ligases is very
limited, including identiﬁcation of the precise substrates of many
E3 Ub ligases and their relevant functions. Similarly, the molecular
mechanisms relating to SUMOylation and ISGylation during poxvi-
rus life cycles are poorly understood. It will also be important to
determine whether the E3 Ub ligases encoded by poxviruses have
the proteasome trafﬁcking function as predicted by their se-
quences. Given the intricacy of the interplay between poxviruses
and their hosts, future research on how the Ub/Ubl systems
become re-conﬁgured in the poxvirus life cycle may shed light
on novel host cell functions of these key host cell pathways in
the absence of viral infections as well.Note in proof
After the submission of this review, two papers (Orthopoxvirus-
es Require a Functional Ubiquitin-Proteasome System for Produc-
tive Replication. Teale A, Campbell S, Van Buuren N, Magee WC,
Watmough K, Couturier B, Shipclark R, Barry M. J. Virol. 2008
December 24. Inhibition of the Ubiquitin-Proteasome System Pre-
vents Vaccinia Virus DNA Replication and Expression of Intermedi-
ate and Late Genes. Satheshkumar PS, Anton LC, Sanz P, Moss B. J.
Virol. 2009 January 7) were published online. These two papers re-
port that the host cell proteasome is required during vaccinia virus
infection.
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